Ascil Biopharm

About Ascil Biopharm

Formed in 2012, our first business unit is internal projects of controlled-release formulations and Medical device projects. The second business unit is R&D and CDMO services for non-GMP or GMP operations with manufacturing capabilities for early-phase clinical batches (parenteral products). 

  • ES
  • 2021
    On CPHI since
  • 1
    Certificates
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator
Primary activities
Analytical Services
Contract Manufacturer
Laboratory Services
Laboratory, Analytical, Biotechnology Equipment
Medical Devices
Packaging & drug delivery
Technology
Contact info
  • Av. Universitat Autonoma, 1B, 08290, Cerdanyola del Valles, Spain

Products from Ascil Biopharm (3)

  • Analytical and Phy-Chem Department

    Product Analytical and Phy-Chem Department

    • Setup and development of analytical methods • Analytical support to formulation and process studies • QC testing of batches involved in in-vivo studies and supervision of bioanalysis • QC Testing of GMP batches • Microbiology (monitoring of GMP Pilot Plant) • Non-G...
  • Clinical Department

    Product Clinical Department

    • Supervision of IBs, protocols and related documents • Initiation and follow-up of clinical trials • Selection and contact of CROs
  • Formulation, Process & Device Department

    Product Formulation, Process & Device Department

    • Compatibility studies and preformulation • Formulation and lab-scale batches • Definition and supervision of in-vivo studies • Non-GMP and GMP activities • Med-Tech workshop for device prototyping